Elie Isenberg-Grzeda1, Yesne Alici2, Vaios Hatzoglou3, Christian Nelson2, William Breitbart4. 1. Department of Psychiatry, Sunnybrook Health Sciences Center, Ontario, Canada. Electronic address: eisenberggrzeda@sunnybrook.ca. 2. Department of Psychiatry and Behavioural Sciences, Memorial Sloan Kettering Cancer Center, Manhattan, NY. 3. Department of Radiology, Memorial Sloan Kettering Cancer Center, Manhattan, NY. 4. Memorial Sloan-Kettering Cancer Center, Manhattan, NY.
Abstract
BACKGROUND: Wernicke-Korsakoff Syndrome (WKS) is a neuropsychiatric syndrome caused by thiamine deficiency. Cancer predisposes to thiamine deficiency through various mechanisms. Although many case reports exist on nonalcoholic WKS in cancer, larger qualitative studies are lacking. METHOD: Retrospective study of patients admitted to a cancer hospital and diagnosed with WKS during routine care on a psychiatric consultation service. Only patients with at least 1 additional supporting feature (magnetic resonance imaging findings, low serum thiamine concentrations, or response to treatment) were included. Data pertaining to demographics, risk factors, phenomenology, and outcomes were abstracted from medical records by chart review. RESULTS: In all, 18 patients were included. All patients developed WKS during cancer treatment. Hematologic malignancy, gastrointestinal tract tumors, low oral intake, and weight loss were common risk factors. All patients presented with cognitive dysfunction, most commonly impaired alertness, attention, and short-term memory. All were diagnosed by operational criteria proposed by Caine et al., 1997 (where 2 of the following are required: nutritional deficiency, ocular signs, cerebellar signs, and either altered mental status or mild memory impairment). Few exhibited Wernicke's classic triad. Diagnostic and treatment delay were common. Only 3 patients recovered fully. CONCLUSION: Nonalcoholic WKS can occur during cancer treatment and manifests clinically as delirium. Diagnosis should be made using operational criteria, not Wernicke's triad. Most patients were not underweight and had normal serum concentration of vitamin B12 and folate. A variety of mechanisms might predispose to thiamine deficiency and WKS in cancer. Given the high frequency of residual morbidity, studies should focus on decreasing diagnostic and treatment delay.
BACKGROUND:Wernicke-Korsakoff Syndrome (WKS) is a neuropsychiatric syndrome caused by thiamine deficiency. Cancer predisposes to thiamine deficiency through various mechanisms. Although many case reports exist on nonalcoholic WKS in cancer, larger qualitative studies are lacking. METHOD: Retrospective study of patients admitted to a cancer hospital and diagnosed with WKS during routine care on a psychiatric consultation service. Only patients with at least 1 additional supporting feature (magnetic resonance imaging findings, low serum thiamine concentrations, or response to treatment) were included. Data pertaining to demographics, risk factors, phenomenology, and outcomes were abstracted from medical records by chart review. RESULTS: In all, 18 patients were included. All patients developed WKS during cancer treatment. Hematologic malignancy, gastrointestinal tract tumors, low oral intake, and weight loss were common risk factors. All patients presented with cognitive dysfunction, most commonly impaired alertness, attention, and short-term memory. All were diagnosed by operational criteria proposed by Caine et al., 1997 (where 2 of the following are required: nutritional deficiency, ocular signs, cerebellar signs, and either altered mental status or mild memory impairment). Few exhibited Wernicke's classic triad. Diagnostic and treatment delay were common. Only 3 patients recovered fully. CONCLUSION: Nonalcoholic WKS can occur during cancer treatment and manifests clinically as delirium. Diagnosis should be made using operational criteria, not Wernicke's triad. Most patients were not underweight and had normal serum concentration of vitamin B12 and folate. A variety of mechanisms might predispose to thiaminedeficiency and WKS in cancer. Given the high frequency of residual morbidity, studies should focus on decreasing diagnostic and treatment delay.
Authors: L F Bleggi-Torres; B C de Medeiros; B Werner; J Z Neto; G Loddo; R Pasquini; C R de Medeiros Journal: Bone Marrow Transplant Date: 2000-02 Impact factor: 5.483
Authors: P J Thornalley; R Babaei-Jadidi; H Al Ali; N Rabbani; A Antonysunil; J Larkin; A Ahmed; G Rayman; C W Bodmer Journal: Diabetologia Date: 2007-08-04 Impact factor: 10.122
Authors: Zev M Nakamura; Allison M Deal; Donald L Rosenstein; Laura J Quillen; Stephanie A Chien; William A Wood; Thomas C Shea; Eliza M Park Journal: Contemp Clin Trials Date: 2020-06-30 Impact factor: 2.226
Authors: Gary E Gibson; Joseph A Hirsch; Pasquale Fonzetti; Barry D Jordan; Rosanna T Cirio; Jessica Elder Journal: Ann N Y Acad Sci Date: 2016-03-11 Impact factor: 5.691
Authors: Zev M Nakamura; Allison M Deal; Eliza M Park; Laura J Quillen; Stephanie A Chien; Kate E Stanton; Sean D McCabe; Hillary M Heiling; William A Wood; Thomas C Shea; Donald L Rosenstein Journal: J Psychosom Res Date: 2021-04-27 Impact factor: 4.620
Authors: Cathrine A McKenzie; Valerie J Page; W David Strain; Bronagh Blackwood; Marlies Ostermann; David Taylor; Peter E Spronk; Daniel F McAuley Journal: Syst Rev Date: 2020-06-05